Transparent blue capillary with a gold ribbon and sample-like forms; conceptual quality-control illustration, not certification.
AI-generated conceptual editorial illustration; not a verified molecular structure.

Checking a regulatory claim at its source

A search should identify the record supporting the claim.

Read country, product and scope before copying “approved.”

A search should identify the record supporting the claim.

Choose the appropriate register

For a US approval claim, FDA describes Drugs@FDA as an approved-product database. For Mexico, COFEPRIS offers its medicine-register search. Compare the name, presentation or form, holder and available indication, and retain the consulted record. No specific commercial product’s status was checked here.

Do not conflate presence and approval

The US label repository warns that it includes company-submitted information and that a label’s presence does not itself establish approval. A reading record should name the database supplying the result. If the match cannot be established, keep the claim pending confirmation.

Professional context / Contexto profesional

The Mexican search page was located through official sources; its direct interface could not be checked in this review.

Evidence / Evidencia

Documentary method, without a legal determination about a product.

Limitations / Limitaciones

Recheck records and validity before publication or a decision.

References

  1. U.S. Food and Drug Administration. About Drugs@FDA
  2. COFEPRIS. Buscador de Registros Sanitarios de Medicamentos
  3. U.S. Food and Drug Administration. FDA Online Label Repository: Important Disclaimer
A community-based bilingual scientific education initiative for healthcare professionals and the general public across the Americas.Currently self-funded; no current sponsors. Formal governance and legal documentation pending.info@peptideamericas.org · Planned contact address — not active yet; please do not send messages.